About Certis Oncology

Certis Oncology Solutions was formed in 2016 with the mission to provide individualized precision patient care.

Certis Oncology Solutions was formed in 2016 with the mission to provide individualized precision patient care. Our patient-directed therapy enables oncologists to tailor and optimize therapies for patients suffering from aggressive cancers. We also provide pre-clinical services, including tumor banking, for pharmaceuticals and biotech companies.

The differentiator for all of our services is the Certis PDOX technique. PDOX stands for Patient-Derived Orthotopic Xenografts. With this technique, we take a very small specimen of a human patient’s tumor and surgically implant it into the corresponding anatomic location (pancreas, liver, lung, etc.) in immuno-deficient mice. This enables us to simultaneously test multiple therapies in multiple mice.

In numerous published peer-reviewed studies, we have demonstrated the ability of our tumors to not only grow in mice at a high rate, but to also replicate tumor growth and metastasis in humans. Certis Oncology is affiliated with leading cancer physicians from UCLA, UCSD and Memorial Sloan Kettering.

For more information on Certis Oncology, please contact us at info@certisoncology.com.

about pdox